Dicyclomine HCl + Mefenamic AcidThird Party Manufacturing in India

Dicyclomine HCl + Mefenamic Acid works via a combined approach to treat visceral spasms and localized pain. Dicyclomine acts as an anticholinergic agent that blocks muscarinic receptors to relieve smooth muscle contractions in the GI and pelvic tracts, while mefenamic acid inhibits cyclooxygenase to reduce uterine and intestinal prostaglandin synthesis. It calms muscle contractions and pain pathways to help the body resolve intense abdominal or menstrual cramping. Unlike standalone analgesics, it directly stops smooth muscle hypermotility. It is highly effective and well-tolerated.

Therapeutic Uses

• Spasmodic Dysmenorrhea: It relieves severe uterine cramping and associated pain during menstrual cycles.
• Irritable Bowel Syndrome: It manages acute abdominal spasms, bloating, and hypermotility discomfort.
• Ureteric and Biliary Colic: It controls sharp visceral pain caused by smooth muscle contractions in the urinary or biliary tracts.

Why Manufacturers Choose Dicyclomine HCl + Mefenamic Acid

This anti-spasmodic combination is a standard therapeutic option in women's health and gastroenterology segments. Utilizing Dicyclomine HCl + Mefenamic Acid third party manufacturing in India helps commercial distributors service high ongoing retail demand. Our partner facilities follow precise quality benchmarks where our production facilities are WHO-GMP certified to ensure stable, reliable blending of CAS number 67-92-5.